Margitta Worm - Concepedia

Author

Margitta Worm

Charité - Universitätsmedizin Berlin ORCID

Also Known As

André Franke, Bindslev‐Jensen, C., Graham Roberts, H. Lee, Ingrid Voigtmann, M WORM, M Worm, M. WORM, M. Worm, M. Worm et al.

1.1K

Publications

41.6K

Citations

H-Index

209

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Ludwig-Maximilians-Universität München Medizinische Hochschule Hannover University Hospital Carl Gustav Carus

About

Margitta Worm is an author at Charité - Universitätsmedizin Berlin specializing in medicine, allergy, and allergy medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	50	123	12.8K
2	Health Sciences	9	9	342
3	Engineering	2	2	33
4	Natural Sciences	1	1	13
5	Nursing	1	1	11

Margitta Worm

350

Publications

31.5K

Citations

H-Index

Page 1

	Year	Citations
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, New England Journal of Medicine	2016	2K
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy Antonella Muraro, Thomas Werfel, Karin Hoffmann‐Sommergruber, Allergy AsthmaClinical ImmunologyFood AllergyAllergy MedicineAllergen	2014	1.3K
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology Antonella Muraro, Graham Roberts, Margitta Worm, Allergy AsthmaClinical ImmunologyAllergy MedicineAllergenDrug Allergy	2014	1K
World Allergy Organization Anaphylaxis Guidance 2020 Victòria Cardona, Ignacio J. Ansotegui, Motohiro Ebisawa, World Allergy Organization Journal	2020	999
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis Graham Roberts, Oliver Pfaar, Cezmi A. Akdiş, Allergy	2017	742
Anaphylaxis in children and adolescents: The European Anaphylaxis Registry Linus Grabenhenrich, Sabine Dölle, Anne Moneret-Vautrin, Journal of Allergy and Clinical Immunology AllergyAllergy MedicineEuropean Anaphylaxis RegistryPediatricsAnaphylaxis	2016	584
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines F. Estelle R. Simons, Motohiro Ebisawa, Mario Sánchez‐Borges, World Allergy Organization Journal	2015	579
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial Diamant Thaçi, Eric L. Simpson, Lisa A. Beck, The Lancet AllergyAtopic DermatitisAllergy MedicineModerate-to-severe Atopic DermatitisSkin Allergy	2015	560
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, British Journal of Dermatology	2020	553
EAACI guidelines: Anaphylaxis (2021 update) Antonella Muraro, Margitta Worm, Cherry Alviani, Allergy AsthmaAnaphylaxis GuidelinesClinical EmergencyAllergyAllergy Medicine	2021	515

Page 1